Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831
- Citation:
- J Clin Oncol vol 27 (16) 2638-2644
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA052352, U10 CA037417, U10 CA035269, CA-37404, U10 CA060276, CA-52352, CA-35195, U10 CA037404, U10 CA063848, U10 CA035195, CA-35103, CA-25224, CA-60276, U10 CA035272, U10 CA035101, P30 CA015083, CA-63848, U10 CA035415, U10 CA063849, CA-63826, CA-35415, CA-37417, CA-35272, CA-35269, CA-35101, U10 CA025224, CA-15083, CA-63849, N01 CA015083, U10 CA035103
- Corr. Author:
- Authors:
- Michele Y. Halyard Thomas M. Pisansky Amylou C. Dueck Vera Suman Lori Pierce Larry Solin Larry Marks Nancy Davidson Silvana Martino Peter Kaufman Leila Kutteh Shaker R. Dakhil Edith A. Perez
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Bc3, Bc4, Bc5, Original Reports, Breast Cancer